Develops cancer treatments using patient-derived tumor models.
Jul 2026Revenue $60.7M/yrExpenses $61.7M/yr
No trendCash runway ≈ 9 months from Jul 2026
Figures by year
When will Champions Oncology be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jul 2026, revenue was $60.7M and expenses $61.7M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Apr 2026 | $59.4M | $60.6M | −$1.14M |
| Apr 2025 | $56.9M | $52.4M | $4.55M |
| Apr 2024 | $50.2M | $57.5M | −$7.36M |
| Apr 2023 | $53.9M | $59.1M | −$5.26M |
| Apr 2022 | $49.1M | $48.5M | $607K |
| Apr 2021 | $41.0M | $40.7M | $366K |
| Apr 2020 | $32.1M | $34.0M | −$1.92M |
| Apr 2019 | $27.1M | $26.8M | $270K |
| Apr 2018 | $20.2M | $21.6M | −$1.35M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.